Table 2.
Demographic and clinical characteristics of the critically ill cancer patients with Acinetobacter baumannii infection on the day of admission to the intensive care unit (initial) according to outcome
| Characteristics | Survivors | Nonsurvivors | P |
| Age, years, mean ± SD | 42.6 ± 16.6 | 48.1 ± 19.3 | 0.510 |
| Women, n (%) | 8 (47) | 3 (50) | 0.901 |
| APCAHE II score, mean ± SD | 12.7 ± 5.0 | 15.3 ± 7.9 | 0.357 |
| SOFA score, mean ± SD | 8.4 ± 2.4 | 9.6 ± 2.6 | 0.318 |
| PEEP, cmH2O | 8.4 ± 2.8 | 7.3 ± 2.3 | 0.422 |
| Durations of vasopressors | 7.59 ± 4.2 | 11 ± 4.9 | 0.122 |
| Leukocytes, × 109/L | 8.6 ± 6.9 | 11.6 ± 13.1 | 0.487 |
| Absolute neutrophil count, cells/mm3 | 7.5 ± 6.2 | 10.2 ± 11.2 | 0.472 |
| Lymphocytes, cells/mm3 | 682 ± 542 | 666 ± 871 | 0.959 |
| Platelets, × 109/L | 184.4 ± 149.2 | 112.8 ± 105.0 | 0.291 |
| Sodium, mmol/L | 138 ± 5.85 | 135.3 ± 6.4 | 0.330 |
| Potassium, mmol/L | 3.9 ± 0.51 | 4.0 ± 0.71 | 0.800 |
| Chloride, mmol/L | 109.1 ± 8.74 | 109.3 ± 4.2 | 0.967 |
| Lactate, mmo/L | 2.01 ± 1.29 | 5.2 ± 3.2 | 0.002 |
| Magnesium, mmol/L | 0.93 ± 0.24 | 0.97 ± 0.13 | 0.722 |
| Phosphorus, mmol/L | 1.33 ± 0.46 | 1.28 ± 0.66 | 0.816 |
| Hemoglobin, g/L | 91.3 ± 19.2 | 94.5 ± 18.8 | 0.739 |
| Creatinine, μmol/L | 75.8 ± 39.01 | 133.2 ± 34.4 | 0.004 |
| Glucose, mmol/L | 8.34 ± 3.5 | 8.09 ± 2.2 | 0.877 |
| Bilirubin, total, μmol/L | 17.8 ± 12.5 | 22.5 ± 15.5 | 0.465 |
| Uric acid, μmol/L | 219.0 ± 94.0 | 189.3 ± 149.0 | 0.576 |
| ARDS, n (%) | 13 (76.4) | 4 (66.6) | 0.632 |
| Number of organ dysfunction (≥ 4) | 2 (11.7) | 4 (66.6) | 0.021 |
| Malignancies | |||
| Hematological malignancy, n (%) | 8 (47) | 6 (100) | 0.030 |
| Solid tumor, n (%) | 9 (52.9) | 0 (0) |
APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IQR: Interquartile range; PEEP: Positive end expiratory pressure; ARDS: Acute respiratory syndrome distress.